Ruskinn Life Sciences is heralding a breakthrough in IVF treatment at the European Society of Human Reproduction and Embryology (ESHRE) annual conference with the unveiling of Ac-tive®, an innovative new technology capable of significantly boosting in-vitro fertilisation (IVF) conception rates.
More...